Please ensure Javascript is enabled for purposes of website accessibility
Skip to main content
Focused on muscle and
positioned for growth

SEC Filing

SEC Filing Details

Document Details

Form
Filing Date
Feb 23, 2024
Document Date
Feb 21, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Dyne Therapeutics, Inc.
Issuer
DYNE THERAPEUTICS, INC.
Filer
Atlas Venture Fund XI, L.P.